Navigation Links
Duane Reade Holdings, Inc. to Report Fourth Quarter and Full Year 2007 Financial Results

NEW YORK, March 7 /PRNewswire/ -- Duane Reade Holdings, Inc. today announced that on Thursday, March 13, 2008 the Company will report fourth quarter and full year 2007 financial results before the open of the market.

In conjunction with the release, the Company will hold a conference call on Thursday, March 13, 2008 at 10:00 a.m. Eastern time. David D'Arezzo, Interim Chief Executive Officer and Chief Marketing Officer, and John Henry, Senior Vice President and Chief Financial Officer, will host the call.

The conference call will also be broadcast live over the Internet and can be accessed via the Investors Information section of the Company's website at An online archive of the broadcast will be available approximately one hour after the completion of the call and will be accessible at the same location through March 27, 2008.

About Duane Reade

Founded in 1960, Duane Reade is the largest drug store chain in the metropolitan New York City area, offering a wide variety of prescription and over-the-counter drugs, health and beauty care items, cosmetics, greeting cards, photo supplies and photofinishing. As of December 29, 2007 the Company operated 242 stores.

For: Duane Reade Holdings, Inc.

Approved By: John Henry

(212) 273-5746

SVP -- Chief Financial Officer

Contact: Cara O'Brien/ Caren Barbara

Press: Diane Zappas

(212) 850-5600


SOURCE Duane Reade Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Duane Reade Holdings, Inc. to Report Third Quarter 2007 Financial Results
2. Study suggests antibiotic may prevent dreaded brain fever
3. Single reader with CAD more efficient, yields fewer false positives, and possibly more sensitive
4. Computer-Aided Detection in Screening Mammography Enhances Performance of a Single Reader
5. ClassMate Reader - Portable reading system supports K-12 students with reading difficulties
6. Financial Times Selects CAMFED International for 2007 Reader Seasonal Appeal
7. Struggling male readers respond better to female teachers
8. Whitemark Homes Signs Letter of Intent to Acquire Metiscan Holdings, Inc.
9. Vallon Holdings, LLC Launches New Subsidiary Focused on Contract Resources for the Minneapolis-St. Paul Life Science Industry
10. NightHawk Radiology Holdings, Inc. Announces Board Member Departure
11. NightHawk Radiology Holdings, Inc. to Speak at the Cowen and Company 28th Annual Health Care Conference on March 18, 2008
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays taken ... for accurate interpretation by the radiologist. The marking utensils are so small, however, ... has found a way to alleviate this problem. , He developed the patent-pending ...
(Date:12/1/2015)... ... December 01, 2015 , ... Visage accelerates ... a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced they ... Society of North America (RSNA) 2015 annual meeting through December 3 in Chicago, ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, announced ... the United States. Clarity is a Superior Dual Wavelength Platform which combines two ... platform that is easy to own and operate. , For over a decade, ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s ... Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning healthcare ... once a deal is signed. This quick-read guidance suggests that failing to ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 01, 2015 ... addition of the "2016 Europe ... E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, ... their offering. --> ... the "2016 Europe Enteric Disease ...
(Date:12/1/2015)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing ... that the company will present at the LD Micro Main ... Luxe Sunset Boulevard Hotel in Los Angeles, CA. ... will present on Thursday, December 3, at 9:00 am Pacific ... register at least 10 minutes prior to the start of ...
(Date:12/1/2015)... CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached its enrollment target of ... clinical trial of aldoxorubicin in patients with previously treated ... completed in Q1 2016. The Phase 3 trial is a ... Assessment from the FDA at 79 sites in ...
Breaking Medicine Technology: